BACKGROUND AND PURPOSE: Exome sequencing analysis has recently identified a nonsense mutation in fused in sarcoma (FUS) segregating with essential tremor (ET) within a large French-Canadian family. Further characterization of FUS resulted in the identification of additional mutations in ET patients; however, their pathogenicity still remains to be confirmed. The role of FUS in an independent cohort of ET patients from Canada was evaluated. METHODS: The entire coding sequence of FUS in 217 patients diagnosed with ET was analyzed and two missense variants in 219 healthy controls were genotyped by Sanger sequencing. RESULTS: Sequencing of FUS identified a previously reported non-pathogenic mutation p.G174_G175del in one ET patient and two healthy controls, and a novel p.R377W in one patient with family history of disease. This mutation is highly conserved and strongly predicted to be damaging by in silico analysis. CONCLUSION: This study has identified a novel FUS p.R377W substitution in ET patients. Additional genotyping studies in a large number of ET patients and controls are necessary to conclusively define its pathogenicity.
BACKGROUND AND PURPOSE: Exome sequencing analysis has recently identified a nonsense mutation in fused in sarcoma (FUS) segregating with essential tremor (ET) within a large French-Canadian family. Further characterization of FUS resulted in the identification of additional mutations in ET patients; however, their pathogenicity still remains to be confirmed. The role of FUS in an independent cohort of ET patients from Canada was evaluated. METHODS: The entire coding sequence of FUS in 217 patients diagnosed with ET was analyzed and two missense variants in 219 healthy controls were genotyped by Sanger sequencing. RESULTS: Sequencing of FUS identified a previously reported non-pathogenic mutation p.G174_G175del in one ET patient and two healthy controls, and a novel p.R377W in one patient with family history of disease. This mutation is highly conserved and strongly predicted to be damaging by in silico analysis. CONCLUSION: This study has identified a novel FUSp.R377W substitution in ET patients. Additional genotyping studies in a large number of ET patients and controls are necessary to conclusively define its pathogenicity.
Authors: Nicola J Rutherford; Nicole A Finch; Mariely DeJesus-Hernandez; Richard J P Crook; Catherine Lomen-Hoerth; Zbigniew K Wszolek; Ryan J Uitti; Neill R Graff-Radford; Rosa Rademakers Journal: Neurobiol Aging Date: 2010-11-12 Impact factor: 4.673
Authors: Catherine Labbé; Alexandra I Soto-Ortolaza; Sruti Rayaprolu; Andrea M Harriott; Audrey J Strongosky; Ryan J Uitti; Jay A Van Gerpen; Zbigniew K Wszolek; Owen A Ross Journal: Parkinsonism Relat Disord Date: 2013-04-16 Impact factor: 4.891
Authors: C Vilariño-Güell; C Wider; A I Soto-Ortolaza; S A Cobb; J M Kachergus; B H Keeling; J C Dachsel; M M Hulihan; D W Dickson; Z K Wszolek; R J Uitti; N R Graff-Radford; B F Boeve; K A Josephs; B Miller; K B Boylan; K Gwinn; C H Adler; J O Aasly; F Hentati; A Destée; A Krygowska-Wajs; M-C Chartier-Harlin; O A Ross; R Rademakers; M J Farrer Journal: Neurology Date: 2009-06-09 Impact factor: 9.910
Authors: Nancy D Merner; Simon L Girard; Hélène Catoire; Cynthia V Bourassa; Véronique V Belzil; Jean-Baptiste Rivière; Pascale Hince; Annie Levert; Alexandre Dionne-Laporte; Dan Spiegelman; Anne Noreau; Sabrina Diab; Anna Szuto; Hélène Fournier; John Raelson; Majid Belouchi; Michel Panisset; Patrick Cossette; Nicolas Dupré; Geneviève Bernard; Sylvain Chouinard; Patrick A Dion; Guy A Rouleau Journal: Am J Hum Genet Date: 2012-08-02 Impact factor: 11.025
Authors: Peter Hedera; Thomas L Davis; Fenna T Phibbs; P David Charles; Mark S LeDoux Journal: Parkinsonism Relat Disord Date: 2013-05-06 Impact factor: 4.891
Authors: N Parmalee; K Mirzozoda; S Kisselev; N Merner; P Dion; G Rouleau; L Clark; E D Louis Journal: Eur J Neurol Date: 2012-11-01 Impact factor: 6.089
Authors: Hyun Hor; Ludmila Francescatto; Luca Bartesaghi; Sara Ortega-Cubero; Maria Kousi; Oswaldo Lorenzo-Betancor; Felix J Jiménez-Jiménez; Alexandre Gironell; Jordi Clarimón; Oliver Drechsel; José A G Agúndez; Daniela Kenzelmann Broz; Ruth Chiquet-Ehrismann; Alberto Lleó; Francisco Coria; Elena García-Martin; Hortensia Alonso-Navarro; Maria J Martí; Jaume Kulisevsky; Charlotte N Hor; Stephan Ossowski; Roman Chrast; Nicholas Katsanis; Pau Pastor; Xavier Estivill Journal: Hum Mol Genet Date: 2015-07-17 Impact factor: 6.150
Authors: C L Ward; K J Boggio; B N Johnson; J B Boyd; S Douthwright; S A Shaffer; J E Landers; M A Glicksman; D A Bosco Journal: Cell Death Dis Date: 2014-12-11 Impact factor: 8.469
Authors: Félix Javier Jiménez-Jiménez; Hortensia Alonso-Navarro; Elena García-Martín; Ignacio Álvarez; Pau Pastor; José A G Agúndez Journal: Pharmaceuticals (Basel) Date: 2021-05-27